Join the Oncology
Community
Follow Us:  

Quality-of-Life issues

AIP: Perceived Social Support as a Predictor of Disease-Specific Quality of Life in Head-and-Neck Cancer Patients

11/28/11

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

The Journal of Supportive Oncology
In Press, Corrected Proof www.sciencedirect.com/science/article/pii/S1544679411002126


doi:10.1016/j.suponc.2011.09.002 |www.sciencedirect.com/science

  Permissions & Reprints


Original Research

Perceived Social Support as a Predictor of Disease-Specific Quality of Life in Head-and-Neck Cancer Patients

Frank J. Penedo PhD, Lara Traeger PhD, Catherine Benedict MS E-mail The Corresponding Author, Giovana Thomas MD, Jason R. Dahn PhD, Madeline Hernandez Krause MS, W. Jarrard Goodwin MD

 

Department of Psychology, University of Miami, Miami, Florida

Sylvester Comprehensive Cancer Center and Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida

Miami Veterans Affairs Healthcare System, Miami, Florida

Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts

Received 7 June 2011; Accepted 1 September 2011. Available online 16 November 2011.

 

 

Abstract

Background

Treatment for head-and-neck cancer (HNC) can lead to severe decrements in disease-specific quality of life (DSQOL) due to disfigurement and disability in speech, eating, and/or breathing. Psychosocial factors such as social support may explain individual variance in DSQOL outcomes.

Objective

The researchers sought to evaluate changes in perceived availability of social support from pretreatment to posttreatment and to determine whether decreases in perceived social support predicted poorer posttreatment DSQOL among HNC patients, controlling for disease- and treatment-related factors.

Methods

Participants (n = 32) were newly diagnosed with HNC and were awaiting surgery and/or radiation treatment. Measures included the ENRICHD Social Support instrument (ESSI) to assess perceived social support and the Functional Assessment of Cancer Therapy–Head & Neck (FACT-H&N) to assess DSQOL. Paired-samples t-tests and hierarchical regression analyses were conducted to determine relationships between pretreatment and posttreatment perceived social support and DSQOL.

Results

Perceived social support decreased significantly from pre- to posttreatment (F[31] = –2.71, P < .01). After adjusting for relevant covariates and pretreatment DSQOL, change in perceived social support remained a significant predictor of posttreatment DSQOL (β = 0.47, P < .01).

Limitations

This study included a relatively small sample of HNC patients, which limited power to evaluate mechanisms of observed relationships.

Conclusions

Increased social isolation may be a risk factor for poorer physical recovery from, or adjustment to, treatment-related side effects. Social support may be an important target for psychosocial interventions for patients who face challenging treatment side effects.

 

 

> more Quality-of-Life Issues articles




Current Issue


The Journal of Supportive Oncology Focused on symptom and side-effect management, communication issues, and end-of-life care for patients with cancer.



For past issues, click here »


calendar
Jun 1 - 5
Chicago, IL
American Society of Clinical Oncology (ASCO): Annual Meeting
Jun 14 - 17
Amsterdam,
European Hematology Association (EHA): Annual Congress
Jun 18 - 21
Lake Tahoe, NV
American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges
Jun 20 - 22
Milan,
European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference
Jun 25 - 26
London,
Teenage Cancer Trust (TCT): International Conference
Jun 27 - 30
Barcelona,
European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer
Jun 27 - 30
Boston, MA
American Association for Cancer Research (AACR): Chemical Systems Biology
Jun 28 - 30
New York, NY
Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium
Jun 28 - 29
Paris,
WIN 2012 Symposium
Jul 7 - 10
Barcelona,
22nd Biennial Congress of the European Association for Cancer Research
More Calendar »